Orchard Therapeutics, SIRION Biotech partners for gene therapy

Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb receives positive CHMP Opinion recommending Sprycel for Pediatric Patients

Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb, Boston Medical Centre announce collaboration

Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...

December 18, 2018 | Tuesday | News
Merck launches new Steritest NEO Device

Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...

December 18, 2018 | Tuesday | News
Lilly to acquire Pre-Clinical Pain Program from Hydra Biosciences

Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-cli...

December 17, 2018 | Monday | News
Lilly announces positive top-line results for Taltz

Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...

December 17, 2018 | Monday | News
Zymergen announces $400M in Series C Funding

Molecular manufacturing technology company, Zymergen has announced that it has raised over $400 million in Series C fund...

December 17, 2018 | Monday | News
The Changing API Industry

Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...

December 17, 2018 | Monday | Opinion
Big data discloses genetic behavior of brain disorders

Psychiatric disorders’ many complexities have stymied scientists looking for clear genetic culprits. But a new gia...

December 17, 2018 | Monday | News
Generex receives IND approval from FDA

Generex Biotechnology Corporation has announced that the FDA had reviewed the company’s investigational new drug (...

December 14, 2018 | Friday | News
Cambridge Heartwear launches first AI-Driven Wearable 'Heartsense monitor'

Cambridge Heartwear, a medical provider of low-cost, next-generation wearable heart monitors that uses artificial i...

December 14, 2018 | Friday | News
Amgen, Direct Relief Partner to help cancer patients In 18 countries

Amgen and Direct Relief today announced a joint initiative in which Direct Relief will distribute $93 million ...

December 14, 2018 | Friday | News
Health Canada warning: Health products by Botanicals Inc. may be harmful

Health Canada is warning that all products manufactured by Professional Botanicals Inc. may pose serious healt...

December 14, 2018 | Friday | Regulatory
Merck collaborates to develop vaccines against dengue

Merck, known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit produc...

December 14, 2018 | Friday | News
Researchers discover new compound to treat breast cancer

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...

December 13, 2018 | Thursday | News
Key to reliable hygiene and HACCP management- MVP ICON

Most contaminants are invisible to the naked eye. Micro-organisms are fairly small, they pose a severe threat to the saf...

December 13, 2018 | Thursday | News
Novo Nordisk acquires platform for cell line development

Berkeley Lights, Inc. and Novo Nordisk have announced that Novo Nordisk has purchased the Beacon Optofluidic platform to...

December 13, 2018 | Thursday | News
Menarini to sell Meropenem/vaborbactam in Europe, Asia-Pacific and CIS

The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in...

December 12, 2018 | Wednesday | News